Literature DB >> 32319346

Post-traumatic stress following total hysterectomy for benign disease: an observational prospective study.

Jvan Casarin1, Marta Ielmini2, Antonella Cromi1, Antonio Simone Laganà1, Nicola Poloni2, Camilla Callegari2, Fabio Ghezzi1.   

Abstract

PURPOSE: Over the last decade, there has been growing interest in the psychophysical integrity of surgical patients in the context of healthcare events. In the present study, we aimed to evaluate the incidence rate of postoperative distress symptoms, namely post-traumatic stress disorder (PTSD), following total hysterectomy for benign disease. We also investigated possible associations between sociodemographic characteristics, clinical outcomes, anxiety, depression, and PTSD.
METHODS: We prospectively enrolled 100 consecutive patients who underwent total hysterectomy for benign disease between 01/01/2019 and 15/04/2019. Demographic and surgical-related characteristics have been registered. The Hospital Anxiety and Depression Scale (HADS) questionnaire was administered preoperatively (Time1), postoperatively (Time2), and at follow-up clinical evaluation, between two and three months after surgery (Time3). PTSD was defined based on the results of the Post-traumatic Stress Disorder Checklist for DSM-5 (PCL-5) at Time3.
RESULTS: At Time3, the median PCL-5 score was 12,8 (0-70), and 16.4% of patients had PTSD symptoms (PCL-5 > 33). No correlation between sociodemographic or gynecologic characteristics and PTSD was detected. A significant association between depression (HADS > 8) at Time2 (p = 0.002) and Time3 (p < 0.001) and PTSD symptoms was shown.
CONCLUSION: Hysterectomy for benign disease is associated with a non-negligible risk of PTDS; the use of the HADS questionnaires might be useful to select patients who might benefit from dedicated psychological support.

Entities:  

Keywords:  Post-traumatic stress; disorder; hysterectomy; laparoscopic surgery; mental health; psychosomatic gynecology

Mesh:

Year:  2020        PMID: 32319346     DOI: 10.1080/0167482X.2020.1752174

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  2 in total

1.  Selective Serotonin Reuptake Inhibitors and Nutraceutical Combination in Major Depression Disorder: A Case-Control Study.

Authors:  Marta Ielmini; Ivano Caselli; Francesca Ceccon; Marcello Diurni; Nicola Poloni; Camilla Callegari
Journal:  Psychopharmacol Bull       Date:  2021-11-03

2.  A Dose-Response Relationship Study of Prophylactic Nalbuphine to Reduce Pain During the Awakening Period in Patients Undergoing Laparoscopic Total Hysterectomy: A Randomized, Controlled, Double-Blind Clinical Study.

Authors:  Min Wang; Dongyue Wang; Jingzhi Zuo; Tianyu Liu; Zheng Niu; Juan Xie; Dunyi Qi
Journal:  Drug Des Devel Ther       Date:  2022-03-31       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.